Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.3K Hold
703
0.03% 117
2026
Q1
$84.6K Hold
703
0.03% 114
2025
Q4
$74K Hold
703
0.03% 120
2025
Q3
$59K Sell
703
-110
-14% -$9.06K 0.03% 145
2025
Q2
$64.4K Buy
813
+113
+16% +$8.98K 0.03% 139
2025
Q1
$62.8K Sell
700
-25
-3% -$2.33K 0.04% 118
2024
Q4
$72.1K Sell
725
-43
-6% -$4.43K 0.04% 113
2024
Q3
$87.2K Buy
768
+54
+8% +$6.42K 0.05% 99
2024
Q2
$88.4K Hold
714
0.05% 94
2024
Q1
$94.2K Hold
714
0.07% 93
2023
Q4
$77.8K Buy
+714
New +$74.1K 0.05% 97

Other funds holding MRK

Aspect Partners's MRK Position: Q2 2026 in Review

Aspect Partners held its Merck (MRK) position steady in Q2 2026 at 703 shares worth $90.3K. The position accounts for 0.03% of the portfolio, ranked #117.

Aspect Partners first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $94.2K in Q1 2024. 1,203 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aspect Partners held 703 shares of Merck worth $90.3K as of Q2 2026.
  • Aspect Partners left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.03% of Aspect Partners's portfolio in Q2 2026, its #117 holding.
  • Aspect Partners first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Aspect Partners's Merck position peaked at $94.2K in Q1 2024.
  • 1,203 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.